Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea

Table 3

Treatment pattern change by age and the Child–Pugh classification in PVT-positive patients.

Treatment n = 605	Age (years)
	≤59	60–69	≥70	value
Surgical resection	16 (4.6%)	5 (3.5%)	1 (0.9%)	0.081
Liver transplantation	3 (0.9%)	3 (2.1%)	0 (0.0%)	0.748
Local ablative therapy	3 (0.9%)	1 (0.7%)	1 (0.9%)	0.996
Transarterial therapy	160 (45.6%)	64 (44.4%)	43 (39.1%)	0.262
Systemic chemotherapy	54 (15.4%)	15 (10.4%)	14 (12.7%)	0.292
Radiation therapy	12 (3.4%)	6 (4.2%)	0 (0.0%)	0.137
No treatment	103 (29.3%)	50 (34.7%)	51 (46.4%)	0.001
n = 605	Child–Pugh classification
	A	B	C	value
Surgical resection	20 (6.3%)	2 (0.9%)	0 (0.0%)	<0.001
Liver transplantation	2 (0.6%)	2 (0.9%)	2 (3.8%)	0.094
Local ablative therapy	4 (1.3%)	1 (0.4%)	0 (0.0%)	0.211
Transarterial therapy	178 (56.0%)	81 (34.5%)	8 (15.4%)	<0.001
Systemic chemotherapy	46 (14.5%)	34 (14.5%)	3 (5.8%)	0.235
Radiation therapy	13 (4.1%)	5 (2.1%)	0 (0.0%)	0.060
No treatment	55 (17.3%)	110 (46.8%)	39 (75.0%)	<0.001

PVT, portal vein tumor thrombosis.